Validation of predictive and prognostic markers in upper gastrointestinal cancer

Validation of predictive and prognostic markers in upper gastrointestinal cancer - Validation of predictive and prognostic markers

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000030472

Enrollment

800

Registered

2017-12-20

Start date

2017-12-20

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Upper gastrointestinal cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.Histopathologically proven gastric cancer 2.20 years of age and older 90 yearrs of age and younger 3.ECOG performance status 0 or 1 4.No previous treatment (chemotherapy, radootherapy) for any cancer in recent 5 years 5.Patients who can take medecine orally

Exclusion criteria

Exclusion criteria: 1.Synchronous or metachronous (within 5 years) malignancies other than carcinoma in situ or mucosal carcinoma, and multicentric cancer. 2.Patients with severe complication (intestinal paralysis, intestinal obstruction, interstitial pneumonitis, pulmonary fibrosis, severe diabetes, heart failure, renal failure, liver cirrhosis, liver failure, etc.). 3.Patients with infections.

Design outcomes

Primary

Measure	Time frame
Cancer-specific survival	—

Secondary

Measure	Time frame
Overall survival	—

Countries

Japan

Contacts

Public ContactNoriyuki Hirahara

Shimane University Faculty of Medicine Department of Digestive and General Surgery

norinori@med.shimane-u.ac.jp+81-853-20-2232

Outcome results